|
HS Code |
947468 |
As an accredited (4-Bromobenzyl)Methylamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive (4-Bromobenzyl)Methylamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Today, labs and manufacturers keep their eyes open for key intermediates that can help streamline workflows and deliver consistent results. Among these, (4-Bromobenzyl)Methylamine stands out in the toolkit of both synthetic chemists and specialty chemical producers. Its structure, combining a methylamine moiety with the reactive 4-bromobenzyl group, offers possibilities that folks in both discovery and production labs appreciate. From experience working with aromatic amines, a compound like this shows up as a versatile option, both in early-phase research and in optimization of final products.
The backbone of (4-Bromobenzyl)Methylamine comes from the benzylamine family, but with a strategic bromine atom at the para-position. This small change can mean a lot. In practice, this chemical bridge brings a unique blend of reactivity and selectivity that’s hard to find elsewhere. A chemist seeking a building block for pharmaceuticals—let’s say antidepressants, anti-inflammatories, or custom-made biologically active molecules—often looks for such functionality. The para-bromo group opens doors to cross-coupling reactions, including Suzuki or Buchwald-Hartwig aminations. Its methylamine arm supports functionalization, which can bring diversity in targeted synthesis projects. Reliability at this level helps scientists save time and resources, reducing extra work in later synthetic steps.
Weighing in with a molecular formula of C8H10BrN and a molar mass close to 200 g/mol, the physical profile of this compound fits comfortably into the workflows I’ve seen in both small-batch and scale-up environments. While many starting materials require special handling, this amine has found a balance—usually presenting as a colorless to pale yellow liquid, with a moderate boiling point. That kind of physical stability makes storage and use less complicated for the average bench chemist. There’s something to be said for a molecule that plays nice under standard conditions.
Talking with colleagues over the years, a consistent theme emerges: researchers and process developers want chemical intermediates that are predictable, practical, and adaptable. (4-Bromobenzyl)Methylamine fits into many programs focused on drug discovery and material science. You see it where people want to fine-tune the electronic characteristics of a target molecule. This is especially true in fields like organic electronics, dyes, or even agrochemical research, where benzylamines serve as the base for further modifications.
From direct alkylations to more sophisticated cross-coupling techniques, this compound brings a level of reliability that’s tough to substitute. Many colleagues have praised how the bromine atom acts as a classic leaving group, making palladium-catalyzed reactions more straightforward. That means less time spent troubleshooting and more time spent on pushing the project ahead. Every chemist, whether in academia or industry, appreciates a reagent that helps projects run smoother. Buying bulk chemicals is one thing, but finding a versatile, high-purity intermediate can truly cut down on batch-to-batch surprises.
I’ve come across reports where (4-Bromobenzyl)Methylamine played a part in the synthesis of active pharmaceutical ingredients, specialized polymers, or functionalized surfaces. Sometimes, it’s used directly; other times, it becomes a means for producing derivatives with tailored properties. Its use spans bench-top innovation and scaled-up commercial production. Flexibility like this is what makes a good tool for so many groups working to solve some of the most pressing chemistry challenges today.
Walking through catalogs or speaking to suppliers, you realize just how crowded the field of benzylamines really is. There are plenty of simple benzylamines, yet few have the distinct combination offered by (4-Bromobenzyl)Methylamine. Replace that bromine with a different halogen or remove it entirely, and the reactivity profile shifts noticeably. For example, the unsubstituted benzylmethylamine loses the cross-coupling potential and some of the physicochemical properties that the bromine imparts.
Other types of substituted benzylamines, such as those with nitro or methoxy groups at the para-position, bring their own set of reactivities and safety concerns. Experience tells me that bromine tends to sit in a useful sweet spot—not as reactive as iodine, which can sometimes lead to unwanted side-reactions, but more versatile than chloride’s sluggishness. That means, for most cross-coupling protocols, (4-Bromobenzyl)Methylamine finds a home in the middle, making it adaptable in a wide range of transformations without demanding constant adjustments to reaction conditions.
In cases where alternatives compete—like (4-Chlorobenzyl)Methylamine or (4-Fluorobenzyl)Methylamine—the differences become clear in yield, purity, and ease of product isolation. The bromine derivatives usually outperform in Suzuki couplings or direct substitution reactions, often thanks to their reactivity tuned just right to support complex synthetic routes. I’ve had colleagues mention easier scale-up and cleaner product profiles when switching to bromine-based intermediates for certain pharmaceutical targets.
One of my earliest experiences in a process chemistry group involved troubleshooting a project that seemed to stall during a key amination step. The initial choice of a chloro-analogue for the coupling reaction kept returning messy profiles, with low conversion and major purification headaches. A switch to (4-Bromobenzyl)Methylamine, suggested by a more senior colleague, changed the pace. Yields nearly doubled and the crude product crystallized out of the reaction mixture almost on its own. Suddenly, the team’s focus could shift to downstream challenges instead of hammering away at one stubborn transformation.
Such “lightbulb” moments aren’t rare with thoughtfully designed intermediates. Reviewing the literature, it’s clear this class of compound pops up regularly in syntheses ranging from designer ligands for catalysis to linkers in small-molecule libraries. The ability to serve as both an amine and an aryl group donor in carbon-nitrogen bond formation is well-documented. A major advantage comes in medicinal chemistry campaigns, where small changes in the structure of a candidate molecule can lead to big swings in efficacy or selectivity. Fine-tuning with a molecular handle like 4-bromo guarantees researchers more options for subsequent adjustments.
I’ve watched as start-ups and established pharmaceutical groups both benefited from switching to brominated intermediates during lead optimization. Less troubleshooting, lower costs, and fewer setbacks always make for happier project managers. This isn’t about chasing some theoretical advantage, but about reducing waste, improving reproducibility, and delivering solid outcomes at each stage. In the world of high-stakes chemistry, the little things really add up.
No matter how reliable or famous a molecule becomes, safety and integrity always sit at the forefront. (4-Bromobenzyl)Methylamine follows standard best practices for aromatic amines: Keep to well-ventilated spaces, use gloves and goggles, and pay attention to storage recommendations. Accidents rarely spring from major surprises; they more often come from cutting corners on the familiar. In my years of lab work, I’ve learned that double-checking chemical compatibility—caps, bottles, and secondary containment—prevents those “wish I’d caught it sooner” moments.
Years of handling this class of intermediates have shown me that moisture and strong oxidizers are the real enemies. Simple practices, like using desiccators and clear labeling, keep stocks in good shape. Teams that commit to regular inventory checks avoid headache-inducing surprises. Some of the smoothest projects I’ve worked on came out of clean labs, not just clever chemistry. Responsible use and tidy habits go much further than fancy technology.
You don’t need to look far to see that demand for intermediates like (4-Bromobenzyl)Methylamine has grown in step with the rise of complex synthetic targets in pharma and materials science. Suppliers who can keep up on purity, consistency, and tight delivery windows have found steady business. This matters because researchers and manufacturers both need products that won’t cause unpredictability at scale. The supply chain issues revealed during the last few years—as seen in so many industries—have highlighted just how critical a stable source of key compounds can be.
Competition in this sector encourages producers to invest in both modern processes and transparency. Buyers ask about not just price and purity, but traceability, impurity profiles, and batch-to-batch quality tracking. With the paradigm shifting toward “Quality by Design”, intermediates like (4-Bromobenzyl)Methylamine satisfy two core needs: synthetic flexibility and supply chain reliability. The ability to maintain consistent composition and deliver material with documentation ready helps both regulatory compliance and peace of mind. In my own purchasing experience, clear communication and reliable data stood out just as much as technical specs.
Lab managers and procurement officers weigh turnaround times, logistics, and support just as much as the chemistry itself. Reliable intermediates have become key assets, especially as research timetables shrink and regulatory expectations rise. Having seen both sides—on the bench and at the negotiating table—I know that transparency, responsiveness, and a real understanding of end-user needs play as much a role as the product sitting in a bottle.
Interest in functionalized aminomethyl aromatics keeps growing. As drug libraries get more diverse and electronics become more sophisticated, molecules like (4-Bromobenzyl)Methylamine see higher demand. Younger chemists and start-up teams focus on modularity and “clickable” synthetic routes. Being able to swap one functional group for another, or build in diversity late in a synthesis, demands intermediates that check all boxes: reactivity, purity, and practical handling.
Current literature highlights efforts to adapt such molecules for greener syntheses—lowering solvents, moving to flow chemistry, cutting down on hazardous byproducts. The adaptability of the bromobenzyl core supports this push. For example, switching away from harsher halogenating reagents makes for safer and more responsible production. From my own work, projects tied to sustainability and waste minimization always benefit from a solid foundation of reliable intermediates.
The need for compounds that marry ease of use with wide compatibility shows up in almost every research proposal and industrial project I’ve reviewed. From designing selective ligands to new types of molecular sensors, (4-Bromobenzyl)Methylamine sits right in the middle of progress. Developers focus on integrating well-characterized, widely supported intermediates instead of new, unproven chemicals that might raise regulatory headaches or introduce unpredictable results into sensitive syntheses.
Over the years, teams have learned that quality issues aren’t always caught by a quick glance at a product’s certificate of analysis. Impurities, trace metals, or unreacted materials in (4-Bromobenzyl)Methylamine—while rare from reliable suppliers—can derail months-long studies. Analytical teams now demand HPLC, GC, and NMR data as standard reporting, and with good reason. I’ve seen labs forced to repeat entire sequences because a small impurity in the amine translated into major problems down the chain. A rigorous approach to incoming material testing beats schedule slippage every time.
Communicating real-world feedback to suppliers drives better outcomes for everyone. When an unexpected issue shows up, collaboration between vendor and customer leads to root cause analysis, process improvement, and better products down the line. Stories circle through conferences about a “bad batch” taking down a set of experiments, only for the issue to spark industry-wide upgrades in controls and testing. These lessons stick around longer than the technical details of any one compound.
With stricter rules on both chemical waste and transparency, users expect intermediates like (4-Bromobenzyl)Methylamine to leave a smaller footprint. Moves to reduce hazardous solvents, streamline work-ups, and recycle by-products are now standard. Regulatory agencies push hard for detailed provenance and impurity reporting, especially in pharmaceutical and agrochemical sectors. Choosing well-documented products shortens the paper trail for everyone—chemists, EH&S officers, and auditors all benefit.
From my own time overseeing compliance, early communication about product profiles and process details saves major effort later. Insisting on up-to-date safety data, impurity screenings, and clear documentation sets up both researchers and regulators for success. This attention to detail is no longer a courtesy but a best practice.
The selection of (4-Bromobenzyl)Methylamine as an intermediate or specialty building block isn’t about having access to the flashiest molecule. It reflects a shift in how teams think about process, flexibility, and practical outcomes. In working with cross-disciplinary project groups, I’ve seen success stories repeat: transparent sourcing, solid documentation, and a compound that’s adaptable to both creative and routine chemistries. The bromobenzylmethylamine scaffold checks these boxes, landing somewhere between workhorse and innovation driver.
Anybody managing the journey from early discovery to pilot scale-up wants options—not just theoretical advantages, but real-world, day-to-day workflow enhancements. For bench chemists, this means predictable protocols and fewer detours. For procurement, it’s clearer line-of-sight into inventory and compliance. For managers, it’s projects completed on time and on budget. Over time, the value of trusted intermediates like (4-Bromobenzyl)Methylamine becomes clearer, not just on paper but in real, measurable progress.
Looking to the future, researchers, engineers, and product managers are steering toward more modular, robust, and greener solutions. Compounds already well understood, like (4-Bromobenzyl)Methylamine, form the backbone of such efforts. There’s comfort in choosing an option that has seen success across disciplines and scales, backed up by a record of consistency and solid science. The needs of chemists will keep changing, but the rationale for using practical, proven intermediates is here to stay.